Ernexa Therapeutics Inc.
Price Action
Technical Summary
WEAKENINGErnexa Therapeutics Inc. is in a technical downtrend, trading below key resistance levels with a broken trend structure. Relative strength is weak (RS Rating: 2), showing significant lag compared to the market leaders. Earnings growth of 55% provides fundamental context to the price action. However, price is extended 35% above the 50-day line, increasing the risk of a mean reversion.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $4.87 | +60.74% | ABOVE |
| 50 SMA | $5.80 | +34.83% | ABOVE |
| 100 SMA | $15.10 | -48.22% | BELOW |
| 150 SMA | $21.69 | -63.95% | BELOW |
| 200 SMA | $25.44 | -69.26% | BELOW |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is ERNA in an uptrend right now?
ERNA has a trend score of 1/4 based on Minervini's Stage Analysis. Currently showing broken structure - 1 of 4 trend criteria are met.
Is ERNA overbought or oversold?
ERNA's RSI (14) is 58. The stock is in neutral territory, neither overbought nor oversold.
Is ERNA outperforming the market?
ERNA has a Relative Strength (RS) Rating of 2 out of 99. ERNA is currently lagging the broader market.
Where is ERNA in its 52-week range?
ERNA is trading at $7.82, which is 8% of its 52-week high ($100.50) and 7% above its 52-week low ($1.16).
How volatile is ERNA?
ERNA has a Beta of 0.25 and 52-week volatility of 113%. It's less volatile than the S&P 500 - generally more stable.